U.S., May 21 -- ClinicalTrials.gov registry received information related to the study (NCT06979544) titled 'A Study to Assess the Safety and Efficacy of Oral LPCN 1154A in Women With Severe PPD' on May 13.
Brief Summary: The purpose of this research study is to test the study drug, LPCN 1154A, as a possible treatment for postpartum depression (PPD). The trial aims to determine:
* If LPCN 1154A reduces depressive symptoms in subjects with severe PPD
* How well LPCN 1154A is tolerated and what side effects it may cause
* If LPCN 1154A reduces anxiety symptoms in subjects with severe PPD
Study Start Date: June, 2025
Study Type: INTERVENTIONAL
Condition:
Depression, Postpartum
Depression, Post-Partum
Postpartum Depression (PPD)
Post-Nat...